Abstract:Antipsychotic medications, while crucial in managing severe psychiatric disorders such as schizophrenia and bipolar disorder, are frequently associated with extrapyramidal symptoms (EPS) and tardive dyskinesia (TD). TD, characterized by repetitive, involuntary movements, especially of the face and limbs, poses a substantial clinical challenge due to its often irreversible nature. Conventional management strategies, including dose reduction and switching to atypical antipsychotics, frequently offer limited success, prompting exploration of alternative therapies. This case report highlights the effectiveness of vitamin E, a potent antioxidant, in treating a 28-year-old male with severe antipsychotic-induced EPS and TD, unresponsive to traditional therapies. The patient, who had been receiving paliperidone injections as part of his psychotic disorder treatment regimen, developed marked EPS, including muscle rigidity, a parkinsonian gait, significant motor disturbances as well as tardive dyskinesia. Despite discontinuation of paliperidone and initiation of procyclidine, propranolol, clonazepam, and omega-3 supplements, his symptoms persisted. Introduction of oral vitamin E at 400 IU daily led to a dramatic improvement, with an 80% reduction in EPS and TD symptoms within weeks. The patient's Abnormal Involuntary Movement Scale (AIMS) score decreased from 24 to 4, and his overall quality of life improved significantly. Gradual increase of vitamin E dosage to 1200 IU daily, coupled with tapering of other medications, eventually led to complete resolution of symptoms, as evidenced by an AIMS score of 0. The patient maintained symptom-free status during follow-up, with no recurrence of psychotic symptoms. This case underscores the potential role of vitamin E as a viable adjunctive treatment for TD, particularly in patients who do not respond adequately to conventional therapies. While the literature presents mixed evidence regarding vitamin E's effectiveness, this case adds to the growing body of research suggesting its benefits, especially when introduced early in the disease course. Further large-scale studies are warranted to establish the most effective treatment protocols and identify patient populations most likely to benefit from vitamin E therapy.

Beneficial Effects of EGb761 and Vitamin E on Haloperidol-Induced Vacuous Chewing Movements in Rats: Possible Involvement of S100B Mechanisms

Ginkgo Biloba and Vitamin E Ameliorate Haloperidol-Induced Vacuous Chewingmovement and Brain-Derived Neurotrophic Factor Expression in A Rat Tardive Dyskinesia Model

Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.

The efficacy of Egb761 on haloperidol-induced tardive dyskinesia model male rats and possible mechanism

Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.

The efficacy of treatment and prevention of vitamin E on haloperidol-induced tardive dyskinesia and its pos-sible mechanisms in rats

Efficacy of Vitamin E treatment on haloperidol-induced tardive dyskinesia model rats

Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial.

Treatment of vitamin E on the patients with tardive dyskinesia and possible mechanisms

Effectiveness of Vitamin E in Treatment of Antipsychotic-Induced Tardive Dyskinesia and Extrapyramidal Symptoms: A Case Report

The Effect of Vitamin E Treatment on Tardive Dyskinesia and Blood Superoxide Dismutase: a Double-Blind Placebo-Controlled Trial.

Vitexin Mitigates Haloperidol-Induced Orofacial Dyskinesia in Rats through Activation of the Nrf2 Pathway

Ginkgo biloba for Tardive Dyskinesia and Plasma MnSOD Activity: Association with MnSOD Ala-9Val Variant

Molecular and Behavioral Neuroprotective Effects of Clavulanic Acid and Crocin in Haloperidol-Induced Tardive Dyskinesia in Rats

The effect of extract of Ginkgo biloba plus haloperidol on superoxide dismutase and its relationship to the clinical outcome

Effect of chaihu taoren tang on tardive dyskinesia of rat model

Genome-wide Association Mapping of Loci for Antipsychotic-Induced Extrapyramidal Symptoms in Mice.

Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: A case report

The therapeutic effect of ginkgo biloba extract for male patients with tardive dyskinesia: the role of brain-derived neurotrophic factor genotypes

The Changes of Plasma Superoxide Dismutase,catalase,glutathione Peroxidase,maleic Dialdehyde in Patients with Antipsychotics-Induced Tardive Dyskinesia

Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation Products in Schizophrenic Patients with Tardive Dyskinesia.